ArriVent BioPharma Inc (AVBP)
26.64
-0.31
(-1.15%)
USD |
NASDAQ |
Dec 31, 16:00
26.64
0.00 (0.00%)
After-Hours: 20:00
ArriVent BioPharma Market Cap: 897.69M for Dec. 31, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
CEL-SCI Corp | 25.52M |
AIM ImmunoTech Inc | 12.61M |
IGC Pharma Inc | 26.02M |
NovaBay Pharmaceuticals Inc | 2.936M |
Protalix BioTherapeutics Inc | 138.43M |
Market Cap Related Metrics
Price | 26.64 |
Earnings Yield | -9.85% |